glp-1 vs zepbound Weight Loss: Is or Wegovy More Effective? Eli Lilly's New $299 Month-Long
Description
Discuss your needs with our analyst Please share your requirements with more details so our analyst can check if they can solve your problem(s)
Supports modest weight reduction
Early proof-of-concept and phase 2 studies suggested that tirzepatide can improve both markers of beta cell function and insulin sensitivity compared with selective GLP-1 RA therapy [9, 10]
10.1002/jnr.21483 15 BlevinsT.PullmanJ.MalloyJ.YanP.TaylorK.SchulteisC.et al
&srotate=0)
Tirzepatide is a dual GLP-1 and GIP receptor agonist, meaning it activates two separate hormonal pathways simultaneously
